Pneumatic Nebulizers Market Analysis

Pneumatic Nebulizers Market Analysis

Breath actuated segment was valued at USD 338 million in 2020. The increasing prevalence of asthma, COPD and coronavirus infection in the geriatric population will impel the demand for pneumatic nebulizers products and drive the industry progression. Geriatric population experience various respiratory disorders such as emphysema, chronic obstructive pulmonary disease, asthma, lower respiratory infections and pulmonary hypertension. Treatment of these morbidities require inhaled therapies for that nebulizers are primary required. In addition, rising incidences of respiratory diseases and infection through the world will further boost the demand for pneumatic nebulizers in the industry.
 

North America pneumatic nebulizers market is expected to showcase over 4.8% growth rate through 2027 led by the growing incidence and prevalence of asthma among the population. According to Asthma and Allergy Foundation of America (AAFA), more than 25 million American people suffer from asthma which equals to one in thirteen American people. The asthma prevalence rate in children is also increasing, around 44.3% of American children (under 18 years old) has asthma. In North America, asthma is more common in adult women than men. The high prevalence of asthma will enhance the demand for aerosol therapy, thereby influencing the industry demand of pneumatic nebulizers over the forecast timeframe.